
Company Info
Year Established2020
Contacts
Michael P Weiner, Ph.D.Founder & CEO
Company Description
Abbratech's technology advances develop antibodies with a targeted precision not obtainable using any other available means.

Abbratech's technology advances develop antibodies with a targeted precision not obtainable using any other available means.